Report for OBBR Hosted Workshop on Biospecimen Reference Sets and Drug-Diagnostic Codevelopment Now Available
OBBR is pleased to release its report on the Workshop on Biospecimen Reference Sets and Drug-Diagnostic Codevelopment, held in January 2011. For more information, please click here.
Innovative Molecular Analysis Technologies (IMAT) Program Reissues Funding Announcement
The NCI has reissued funding announcements for the Innovative Molecular Analysis Technologies (IMAT) program. The IMAT program is aimed at the inception, development, integration, and application of novel and emerging technologies in the support of cancer research, treatment, diagnosis, and prevention. Read the notice for details.
NIH Biospecimens Interest Group to Sponsor Seminar on January 26th, 2012
The NIH Biospecimens Interest Group will sponsor a seminar, "Acquisition of Normal Tissues for the GTEx Program", on January 26 from 1:00 - 3:00 pm on the NIH campus, Building 10, Lipsett Auditorium, with live videocast at http://videocast.nih.gov/.
The U.S.-China Workshop on Developing Common Standards for Biorepositories and Biospecimen Research
OBBR is co-sponsoring an international workshop, The U.S.-China Workshop on Developing Common Standards for Biorepositories and Biospecimen Research, with the National Foundation for Cancer Research (NFCR) that will be held in Tianjin, China on October 19th, 2011. The Workshop is designed to advance cancer research by raising awareness about the importance of developing and implementing common standards for biorepositories in the U.S. and China and of the need to initiate a process to identify and agree upon standards that can be implemented in both countries. For more information can be found here or at www.nfcr.org.
Workshop Summary on Return of Research Results Available
OBBR convened a workshop to provide recommendations concerning the conditions and processes for releasing research results to human research participants who contribute biospecimens. Three areas were examined: diagnostic discrepancies and incidental findings, results from clinical studies, and results from basic research studies. Read the publication
New OBBR Brochure Available
OBBR has developed a comprehensive brochure that details the critical role of biospecimens in cancer research, OBBR's role in setting biospecimen standards to ensure high quality, and the benefits of a national, centralized biospecimens resource to address the current shortage of high-quality biospecimens necessary to advance medicine. Read the OBBR brochure
caHUB to Lead Biospecimen Accrual for GTEx
The National Cancer Institute's (NCI) cancer Human Biobank (caHUB) will lead the biospecimen acquisition sub-initiative for the NIH Genotype-Tissue Express (GTEx) project. GTEx seeks to determine how genetic variation controls gene expression and its relation to disease. Read the announcement
OBBR in the News
The work of the OBBR has been featured prominently in several national publications. Read more
